Media Coverage · April 18, 2019
Experimental antiplatelet compound for acute stroke shows promise
April 2019. An experimental antiplatelet compound inhibited clot formation without increasing bleeding, a common and potentially dangerous side effect of current anticlotting therapies, according to new phase I research in Arteriosclerosis, Thrombosis
Read next in 'Media Coverage'
- Novel antiplatelet could circumvent bleeding risk for stroke patients
- New drug to prevent clots clears safety hurdle
- New blood thinner may prevent stroke, without risk for bleeding
- Acticor's blood thinner cuts hemorrhage risk in human study, could offer hope for acute stroke
- Experimental Drug Can Prevent Strokes